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Objectives. Recent studies have suggested that vitamin K may exert signiﬁcant eﬀects on the central nervous system. +e present
study investigates the relationship between vitamin K plasmatic levels and cognitive functions in elderly patients on oral an-
ticoagulant therapy (OAT). Design. At the +rombosis Centre of Haematology, “Sapienza” University of Rome, 85 patients on
OAT, aged between 75 and 92, were randomly enrolled in the study. Patients were on OATwith vitamin K antagonists (VKAs).
Vitamin K1 concentrations were determined using standardized High-Performance Liquid Chromatography (HPLC). Cognitive
functions were assessed using the Milan Overall Dementia Assessment (MODA). Results. MODA scores are positively correlated
to vitamin K1 concentration. Patients with vitamin K1 below 0.100 μg/L and between 0.100 and 0.400 μg/L showed ameanMODA
score of 79± 5 and 82± 3, respectively. Patients with vitamin K1 above 0.400 μg/L had a signiﬁcantly greater MODA score (89± 1).
After binning the data into bicentiles, MODA scores are shown to be linearly dependent on vitamin K1 concentrations (p< 0.001).
Even long-term OAT (>10 years) does not aﬀect MODA scores. Education seems to exert a greater role on the cognitive status in
comparison with aging. Conclusions. +e study shows a positive association between vitamin K1 concentration and cognitive
status in elderly patients (≥75 years) on OAT.+e relationship between vitamin K1 concentration and MODA scores is described
by a linear model. Cognitive status is not inﬂuenced by the duration of OAT but by the years of education.
1. Introduction
Vitamin K includes a group of lipid-soluble molecules based
on a common 2-methyl-1,4-naphtoquinone ring but with a
diﬀerent side chain at the 3-position [1–3]. Phylloquinone
(2-methyl-3-phytyl-1,4-naphtoquinone), or vitamin K1, is
mainly found in vegetables [1, 2]. A second class of vitamers
is the menaquinones (MK). MKs are produced by bacteria as
provitamins and present unsaturated 5-carbon (prenyl) side
chains at the 3-position [1–3]. One of the menaquinones,
MK-4, is not commonly produced by bacteria, but syn-
thesised from vitamin K1 [2, 3]. Vitamin K has a key role in
the carboxylation of glutamate residues in proteins leading
to gamma-carboxyglutamate (Gla) residues. Gla residues
bind calcium and are essential for the activity of the so-called
Gla proteins. Gla-proteins are involved in blood coagulation
(coagulation factors II, VII, IX, and X and protein C, S, and
Z), as well as in bone and vascular metabolism (osteocalcin
and growth arrest-speciﬁc protein 6, Gas-6, respectively)
[1, 2].
Vitamin K has been found in rat and human brain. Here,
the most common vitamer is MK-4 [3, 4]. +ese ﬁndings
have contributed to an increasing interest in the role of
vitamin K in cognitive impairment and neurodegenerative
diseases. Recent studies seem to suggest that vitamin K may
exert some signiﬁcant eﬀects on the central nervous system
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(CNS) [3]. Diﬀerent studies, however, show discrepancies on
whether vitamin K would act as a protection factor against
cognitive impairment or would contribute to neuro-
degeneration and loss of cognitive functions. On the one
hand, Gas-6 helps the development and survival of many
central nervous system’s cellular lines [5]. On the other
hand, Gas-6 has been shown to inhibit, in a concentration-
dependent manner, the overexpression of Tyro3. Tyro-3 is a
tyrosine kinase which reduces β-amyloid production [6].
Vitamin K may inﬂuence cognitive functions through
other vitamin K-dependent proteins. Protein S, for example,
seems to act as a protective factor during ischemic damage
[7] and as a preserving factor for the integrity of the blood-
brain barrier [8].
Vitamin K seems to regulate multiple enzymes involved
in the sphingolipid biosynthesis [3, 9, 10]. Sphingolipids are
present in high concentrations in brain tissues where they
are important membrane constituents and major signalling
molecules [10]. +eir altered metabolism is involved in the
pathological mechanisms leading to β-amyloid accumula-
tion [11] as well as in the development of cognitive im-
pairment in murine models [12, 13].
In the last ﬁve years, clinical observational studies have
started investigating the impact of vitamin K on cognitive
functions [14–16]. An increase in the dietary vitamin K
intake has been shown to improve cognitive performance
in geriatric patients [14, 15]. +is is conﬁrmed by the fact
that a decrease in serum concentrations of vitamin K is
associated with deterioration in verbal episodic memory
[16]. A case control study conducted by our group on the
relationship between vitamin K and the percentage of time
in therapeutic range (TTR%) conﬁrmed that subjects with
low vitamin K1 plasmatic concentrations (below 0.060 μg/
L) were more likely to show signs of neurodegenerative
diseases [17].
+e impact of vitamin K on cognitive functions is in-
directly conﬁrmed by the eﬀects of vitamin K antagonists
(VKAs) which interfering with vitamin K metabolism seem
to worsen neurodegenerative diseases. Rats treated with
VKAs have shown altered MK-4 and sphingolipids levels in
the brain, as well as cognitive and behavioural disorders [13].
Notably, patients on oral anticoagulant therapy (OAT) with
VKAs have shown brain volume abnormalities [18].
Although only a small number of evidences are cur-
rently available, they seem to suggest that vitamin K may
play a crucial role in the biochemistry and pathophysiology
of the CNS. One key point to be explored in human
subjects is whether vitamin K levels are related to the
overall cognitive abilities and mental impairment, rather
than just to some aspects of the cognitive performance.
Given the increasing number of elderly subjects on OAT
[17], it is also crucial to conﬁrm any impacts anticoagulant
drugs may have on vitamin K levels and cognitive func-
tions. +is may shine a light on the multifactorial path-
ogenesis of currently incurable neurodegenerative
diseases. +e present study, hence, investigates the rela-
tionship between plasmatic concentrations of vitamin K1
and the overall cognitive functions in elderly patients on
OAT.
2. Materials and Methods
2.1. Patients. At the +rombosis Centre of Haematology,
“Sapienza” University of Rome, 625 OATpatients older than
75 years are regularly followed as outpatients. Of these, 456
patients are on OAT with VKAs or with direct oral anti-
coagulants (DOACs).
From 1 November 2016 to 15 December 2017, a random
sample of patients has been selected for the study. Of 456
possible patients, 105 were chosen and gave their informed
consent to participate in the study. +e selection method was
that the ﬁrst patient who underwent a prothrombin time/
international normalized ratio (PT/INR) test or other coag-
ulative tests for each hour between 8 a.m. and 11 a.m., from
Monday to Wednesday, was enrolled. Patients were excluded
if their alcohol assumption was higher than a single serving/
day, or if they showed evidences of an active hepatopathy. We
excluded 12 subjects who were on OATwith DOACs. +is is
due to the fact that the limited number of patients treated with
DOACs would not allow any statistically signiﬁcant analysis.
+e ﬁnal cohort was made up of 85 patients.
Education background signiﬁcantly varied ranging from
less than 4 years of studies (lack of primary school diploma)
to more than 17 years (equivalent to university degree).
+ese 85 patients (52 males and 33 females) were aged
between 75 and 92 (mean� 83.4± 0.4) and were on OAT
with VKAs (either warfarin or acenocoumarin). Table 1
shows the distribution of patients by therapeutic indica-
tion. OAT quality was assessed by TTR%. TTR% was cal-
culated according to the Rosendaal method [19], considering
PT/INR values over the last 9months. +e PT/INR target
was 2.5 (range: 2.0–3.0) in patients with atrial ﬁbrillation,
deep venous thrombosis, pulmonary embolism, and arterial
disease [17]. +e PT/INR target was 3.0 (range: 2.5–3.5) in
those with mechanical heart prosthesis [17].
2.2. Specimen Collection and Vitamin K1 Dosage. Blood
collection was performed after an overnight fast. Peripheral
blood samples were obtained by venous puncture. Samples
were collected in three vacutainer tubes containing 0.129M
sodium citrate as an anticoagulant and centrifuged at 2700 g
for 10minutes. Plasma was extracted, aliquoted in Eppen-
dorf tubes, and stored at − 80°C until further analysis.
Vitamin K1 analysis was conducted in the Department of
Chemistry, Sapienza University of Rome, using standardized
High-Performance Liquid Chromatography (HPLC) pro-
cedures. HPLC was performed with a micro HPLC/auto-
sampler/vacuum degasser system PE Series 200 (Perkin
Elmer, Norwalk, CT). Analytes were detected and quantiﬁed
by a 4000 Qtrap® (AB SCIEX, Foster City, CA, USA) massspectrometer, using liquid chromatography-hybrid quad-
rupole linear ion trap mass spectrometry. +e lowest limit of
quantiﬁcation (LLOQ) for vitamin K1 is 0.060 μg/L. +e
concentration values are aﬀected by an error equal to 13% of
the values themselves. +e method may, however, show a
lower precision for values below 0.100 μg/L [20].+emethod
had already been validated according to the Food and Drug
Administration (FDA) guidelines with its accuracy
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evaluated through participation in the Vitamin K External
Quality Assessment Scheme (KEQAS) [20].
2.3. Cognitive Assessment. Diﬀerent tests are currently
available to investigate cognitive functions and abilities. +e
most widely used test is the Mini Mental State Examination
(MMSE) [21]. +is is a rapid 30-point questionnaire which
does not require any training and provides reliable results in
the diagnosis of cognitive impairment. MMSE, however, has
a signiﬁcantly low sensitivity in identifying Mild Cognitive
Impairment (MCI) [22]. +erefore, we decided to use the
Milan Overall Dementia Assessment (MODA) [22–25].
MODA is a test with a signiﬁcantly higher sensitivity in the
detection of signs of MCI [22]. Cognitive evaluation of the
patients was performed after the venous puncture.
+e MODA test is based on a three stages examination:
(1) Autonomy Scale. +is is found altered only in the
most deteriorated patients
(2) Orientation Enquiry. +is part of the test investigates
4 diﬀerent orientation areas: temporal, spatial and
personal orientation, and family relationships
(3) Neuropsychological Tests. +is investigation evaluates
the levels of attention, memory, intelligence, space
cognition, visual perception, and language
We used age and years of school correction tables to
obtain the ﬁnal score for each patient. According to the
protocol’s instructions, cognition values were considered
normal if the score was ≥85/100 and pathological below 80/
100. Values between 80 and 85 are considered borderline.
Even if some authors quote MODA score up to one decimal
place [22, 24, 25], we took the error on the MODA to be ±1.
+is was performed so as to avoid any potential overesti-
mation in the precision of the method.
2.4. Data Analysis. Data was retrieved and statistically
analysed using a speciﬁc program, which was developed by
one of the authors using Python programming language.+e
program evaluated the correlation between MODA scores
and vitamin K1. Data were analysed considering a threshold
value for the vitamin K1 of 0.060 μg/L. +is value is the
LLOQ for the HPLC method [20]. Advanced analysis was
conducted binning the data according to the vitamin K
centiles (0.100–0.199 μg/L, 0.200–0.299 μg/L, and so on) and
bicentiles (0.100–0.299 μg/L, 0.300–0.499 μg/L, and so on).
For each bin, the MODA score and the corresponding error
were taken to be the mean and the standard error, re-
spectively. When binning the data, vitamin K concentrations
below 0.100 μg/L were excluded.+is was performed so as to
remove any potential bias among centiles.+e centile from 0
to 0.100 μg/L would be signiﬁcantly diﬀerent from the
others. +e lower detection limit for vitamin K1 being
0.060 μg/L, this centile would not include any values coming
from the ﬁrst half of the centile itself. Furthermore, the
HPLC method is potentially aﬀected by lower precision for
concentrations below 0.100 μg/L [20]. A further analysis was
conducted according to whether the patients had vitamin K1
plasmatic levels below or above 0.400 μg/L.
Data analysis was performed using Pearson’s chi-
squared, χ2, test. +e χ2 test was implemented into our
custom-made Python program. +e relationship between
MODA scores and vitamin K1 levels was evaluated con-
sidering the reduced χ2 (χ2]). For a system with ] degrees of
freedom, the goodness of the ﬁt is proved for χ2]≈1. +e
other condition to test is whether χ2 is within ±2 standard
deviations of the mean, that is, within the range ] ± 2 ��2]√ .
+e null hypothesis of a relationship between the two
quantities is further tested by the cumulative probability
function (P).+e signiﬁcance threshold being set to less than
0.001 (p< 0.001), P needs to be greater than p so as to not
reject the null hypothesis [26, 27]. Further data analysis on
the goodness of the linear ﬁts is performed assessing the
regression with the Pearson correlation coeﬃcient (r). A
value for r of 1 shows that the linear regression predictions
perfectly match the observed data [27, 28].We evaluated also
the correlations between, on the one hand, MODA scores
and vitamin K1 levels, and, on the other hand, education,
age, OAT length, and comorbidities. Also here, we set a
threshold value for the vitamin K1 of 0.060 μg/L, corre-
sponding to the LLOQ for the HPLC method [20].
3. Results
+e characteristics of all the patients are reported in Table 1.
Out of the 85 patients on OAT, 52 were males and 33
Table 1: Characteristics of patients according to the diagnosis.
Diagnosis AF MHP DVT/PE AD Total
Patients (number) 42 29 7 7 85
Sex Male 26 18 5 3 52Female 16 11 2 4 33
Age (years)
75–80 4 6 3 1 14
80–84 15 16 4 3 38
85–89 20 6 0 3 29>89 3 1 0 0 4
Time of therapy (months)
<24 3 0 0 0 3
24–60 3 0 1 0 4
61–120 6 2 4 1 13>120 28 27 5 5 65
AF: atrial ﬁbrillation. MHP: mechanical heart prosthesis. DVT: deep venous thrombosis. PE: pulmonary embolism. AD: arterial disease.
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females. Out of the entire cohort, 71 (84%) patients were
aged 80 years or above. Atrial ﬁbrillation was the most
common diagnosis among patients (49%) followed by
mechanical heart prosthesis (34%) and by deep venous
thrombosis or pulmonary embolism (8%). Patients enrolled
in the present study had been receiving OAT for at least
18months and 65 (76%) patients for more than 10 years.
As shown in Table 2, vitamin K1 concentration was
below 0.100 μg/L in 27 patients and equal to or above
0.100 μg/L in 58 patients. Considering the patients with
vitamin K1 concentration above 0.100 μg/L, 32 of them had
vitamin levels between 0.100 and 0.400 μg/L; the remaining
26 had vitamin concentrations above 0.400 μg/L.
TTR% tends to increase with vitamin K concentration
(Table 2). Patients with vitamin K levels below 0.100 μg/L
had a mean TTR% of 57 (±6) %. For vitamin K levels be-
tween 0.100 and 0.400 μg/L and above 0.400 μg/L, the mean
TTR% was 66 (±4) % and 61 (±3) %, respectively. +ese
results are consistent with previous observations [17].
Patients’ MODA scores are reported in Table 3. +e
percentage of MODA scores above 90 was higher in patients
younger than 85 years in comparison with older subjects
(38% vs. 29%, respectively). +e frequency of MODA scores
below 80 was almost the same in subjects younger and older
than 85 (22% vs. 20%, respectively).
+e higher MODA scores in subjects younger than 85
years would suggest an impact of aging on the deterioration
of cognitive functions. No clear correlation was however
found between cognitive functions and age (Figure S1 in the
Supplementary Material); this is not surprising given the age
correction factors applied to the MODA scores. Also the
OAT length does not show any clear correlation to the
vitamin K levels and cognitive functions (see Supplementary
Material Figures S2 and S3, respectively). Education instead
seems to exert a greater inﬂuence on the cognitive status.+e
MODA score was below 80 in 3 (9%) subjects with at least 13
years of school and in 11 (41%) patients with less than 7 years
of school. +is is further supported by Figure S4 showing
that, for increasing years of school, the dispersion of MODA
scores tends to decrease and small values are less frequent.
As shown in Table 2, MODA scores are correlated to
vitamin K1. Patients with vitamin K1 below 0.100 μg/L had a
mean MODA value of 79± 5. For vitamin K1 levels between
0.100 and 0.400 μg/L, patients showed a slight increase in the
mean MODA score (82± 3). Patients with vitamin K1 above
0.400 μg/L had a signiﬁcantly greater mean MODA value
(89± 1). Cognitive functions seem to be related to vitamin
K1 levels by a logarithmic-like function with MODA scores
dispersion decreasing for increasing levels of vitamin K1
(Figure 1). +is is conﬁrmed by further analysis dividing the
patients according to vitamin K1 concentration centiles
(Table S1 in the Supplementary Material). For the low
concentration centiles, MODA scores show a large vari-
ability, that is, standard deviation (SD)> 10. An increase in
vitamin K1 above 0.400 μg/L corresponds to a decrease in SD
below 10 (see also Figure 1). +erefore, 0.400 μg/L was taken
to be our threshold value. Given that some centiles have a
very small number of patients, further analysis was per-
formed binning the data into bicentiles. +is is pictorially
represented in Figure 2 showing a linear relationship be-
tween vitamin K1 concentrations and cognitive capacities.
+e goodness of the ﬁt is conﬁrmed by χ2 and χ2] being 1.21
and 0.3, respectively. Here, χ2 is within 2 standard deviations
of the mean, and χ2] is close to the ideal value of 1. +e
hypothesis of a linear relationship between vitamin K1 levels
and cognitive functions is statistically signiﬁcant (p< 0.001)
as shown by the calculated value for the cumulative prob-
ability function P� 0.85 being close to the ideal value of 0.5
[26, 27]. +e r value of 0.94 shows a high positive correlation
between vitamin K levels and MODA scores. +is further
Table 2: MODA scores and percentage of time in therapeutic range (TTR%) according to the plasmatic levels of vitamin K1. For both the
MODA score and the TTR%, the value and the associated error are the mean and the standard error, respectively.
Vitamin K1 (μg/L) <0.060 <0.100 0.100–0.400 >0.400 Total
TTR (%) 59± 4 57± 6 66± 4 61± 3 —
MODA score 81± 4 79± 5 82± 3 89± 1 —
Pts (number) 19 8 32 26 85
Table 3: MODA scores according to patients’ characteristics.
MODA score >90 90–85 84–80 79–70 <70 Total
Sex Male 24 15 7 4 2 52Female 6 9 7 3 8 33
Age (years)
75–80 4 5 1 2 2 14
80–84 15 9 5 2 5 36
85–89 10 8 7 3 3 31>90 0 2 1 0 1 4
Education (years of school)
<4 1 1 2 0 3 7
4–7 5 5 2 2 6 20
8–12 11 6 5 3 1 26
13–16 7 6 4 1 1 19>16 5 6 1 1 0 13
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conﬁrms that the linear regression is a valid model to ﬁt the
data [27, 28].
+e results are particularly remarkable considering that
there do not seem to be any clear relations between, on the
one hand, comorbidities and, on the other hand, vitamin K
plasmatic concentration and cognitive functions (see
Tables S2 and S3 and in Figures S5–S8 in the Supplementary
Material).
4. Discussion
+e role of vitamin K in coagulation processes has been
extensively studied and characterised [29]. Recent studies
have suggested that the vitamin may also play a key role in
cognitive performance [13–16]. Studies on animal models
have suggested that vitamin K may be involved in memory
consolidation. Rats fed with a low vitamin K diet presented
an altered sphingolipid proﬁle in their hippocampus, which
is the key cerebral region for memory [13]. Clinical studies
on human subjects conﬁrmed a positive association be-
tween, on the one hand, serum concentrations and dietary
intake of vitamin K and, on the other hand, cognitive
outcomes in healthy elderly [14–16]. +e large number of
geriatric patients on OAT has suggested the need for
further investigations so as to understand whether treat-
ments with any vitamin K antagonists may aﬀect cognitive
functions.
+e present study is the ﬁrst one, to the best of our
knowledge, that analyses the relationship between vitamin
K1 levels and cognitive performance in elderly patients on
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OAT with VKAs. Previous studies mainly focused on animal
models or human tissues analysed post mortem [30]. Some
investigations had evaluated the relationship between
vitamin K and cognitive functions in human subjects [30].
+ese studies, however, relied on simple cognitive tests, such as
the MMSE. Here, the cognitive functions of the patients have
been assessed using a more accurate test, that is, the MODA
score. +e MODA is a complex tool which allows evaluating
the levels of attention, memory, intelligence, space cognition,
visual perception, and language. +e MODA has shown sig-
niﬁcantly high sensitivity in the detection of MCI signs [22].
+is study shows a positive association between plas-
matic levels of vitamin K1 and cognitive status in patients
older than 75 years on OAT. +ere is a linear relationship
between vitamin K1 concentration per bicentile and cog-
nitive functions as measured by the MODA score. +e
MODA values tend to be borderline or pathological for
vitamin K1 concentrations smaller than 0.400 μg/L. +is
would support the role of vitamin K in ensuring and pre-
serving cognitive functions. Vitamin K1 concentration of
0.400 μg/L may be a threshold value below which important
signs of cognitive impairment appear. +e reasons behind a
positive impact of vitamin K on cognitive status may be
explained with the fundamental role of this vitamin on the
synthesis of protein S [7, 8] and sphingolipids [3, 9, 10].
+ese molecules have been shown to have a key role in
ensuring brain signalling and metabolism [7–10, 30].
Interestingly, the cognitive capacities do not correlate
with the anticoagulant therapy and with its duration. +ese
ﬁndings would suggest that long-term OAT can be pre-
scribed to elderly patients without any major impacts on
their cognitive status.
Education seems to have a greater inﬂuence on cognitive
functions in comparison with aging. Despite applying
correction factors for both education and aging, the former
still seems to inﬂuence MODA scores. Only 9% of subjects
with high education had a MODA score below 80, whereas
low education levels are associated to a pathological MODA
value in 41% of the patients.
Further studies on larger cohorts of patients are needed
so as to conﬁrm the ﬁndings of this investigation.
5. Conclusions
+is pilot study has shown a positive correlation between
vitamin K1 concentration and cognitive status. +is is in
particular true for vitamin K1 concentrations above 0.400 μg/
L. A multicentre research is strongly recommended so as to
conﬁrm the data of the present investigation.
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